Breakthrough research has shown a common steroid given to coronavirus patients could have saved between 4,000 and 5,000 lives in the UK. A third fewer patients on ventilators died when given dexamethasone compared to those given standard NHS care. Leading scientists running the RECOVERY trial say the £6 drug will now become the standard of care for all Covid-19 patients on oxygen in hospitals. By comparison 13% of hospitalised Covid-19 patients died in the 28 day period. “That’s a major, major step forward.

Source: Daily Mirror June 16, 2020 12:07 UTC